Glen Harbor Capital Management’s Novartis NVS Stock Holding History

Glen Harbor Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.12M	Buy	12,864 +1,328	+12%	+$119K	0.02%	450
2019 Q2	$1.05M	Buy	11,536 +5,394	+88%	+$457K	0.02%	465
2019 Q1	$529K	Buy	6,142 +1,589	+35%	+$128K	0.01%	653
2018 Q4	$350K	Sell	4,553 -8,214	-64%	-$639K	0.01%	742
2018 Q3	$986K	Buy	12,767 +696	+6%	+$51.5K	0.02%	474
2018 Q2	$817K	Buy	12,071 +1,393	+13%	+$96.1K	0.02%	485
2018 Q1	$774K	Buy	10,678 +1,214	+13%	+$92.4K	0.02%	480
2017 Q4	$712K	Hold	9,464	–	–	0.02%	533
2017 Q3	$728K	Hold	9,464	–	–	0.02%	480
2017 Q2	$708K	Hold	9,464	–	–	0.02%	493
2017 Q1	$630K	Hold	9,464	–	–	0.02%	497
2016 Q4	$618K	Buy	+9,464	New	+$614K	0.02%	451

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Glen Harbor Capital Management's NVS Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Novartis (NVS) stake by 12% in Q3 2019, buying an estimated $119K and bringing the position to 12,864 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #450.

Glen Harbor Capital Management first reported a position in NVS in Q4 2016 and has held it in 12 quarters since. 1,091 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

Glen Harbor Capital Management held 12,864 shares of Novartis worth $1.12M as of Q3 2019.
Glen Harbor Capital Management bought 1,328 Novartis shares in Q3 2019, an estimated $119K.
Novartis made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #450 holding.
Glen Harbor Capital Management first reported a position in Novartis in Q4 2016 and has held it in 12 quarters since.
1,091 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.